✦ LIBER ✦

Endometrial carcinoma associated with adjuvant tamoxifen therapy for breast cancer: a French multi-centre analysis of 89 cases

✍ Scribed by H. Mignotte; J.F. Rodier; A. Lesur; S. Hoffstetter; B. Cutuli; J. D'Anjou; P. Rouanet; S. Lasry; G. Le Bouedec; J. Dauplat; G. Depad; S. Giard; E. Fondrinier

Book ID: 113404494
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 608 KB
Volume: 4
Category: Article
ISSN: 0960-9776
DOI: 10.1016/0960-9776(95)90077-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endometrial changes associated with tamo

Endometrial changes associated with tamoxifen adjuvant therapy of postmenopausal women with breast cancer: Sonographic and pathologic correlations

✍ M. El-Monayeri; A. Nadim; I. Abdel-Fattah; A. Abbass 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 325 KB

PCN15 PHARMACOECONOMIC ANALYSIS OF EXEME

PCN15 PHARMACOECONOMIC ANALYSIS OF EXEMESTANE VERSUS TAMOXIFEN AS ADJUVANT THERAPY FOR PATIENTS WITH EARLY-STAGE ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

✍ JM Gil; A Lluch; P González; A Del Castillo; F Canorea; C Rubio-Terrés 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

A genome-wide association study identifi

A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese

✍ Kiyotani, K.; Mushiroda, T.; Tsunoda, T.; Morizono, T.; Hosono, N.; Kubo, M.; Ta 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 315 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB